Abstract:Scavenger receptor class B type I (SR-BI) is a major receptor for high-density lipoproteins (HDL) in the liver. Overexpression of SR-BI attenuated experimental atherosclerosis in murine models, concomitant with a reduction in plasma HDL-cholesterol levels. Probucol is known to be a potent hypolipidemic drug to regress xanthoma formation and carotid atherosclerosis in conjunction with a marked reduction in HDL-cholesterol levels. However, the mechanism by which probucol affects atherosclerosis is not completely understood, and the effect of probucol on the expression of SR-BI was controversial. The aim of this study was to know the effect of probucol on HDL metabolism and SR-BI expression in the liver.Sixteen rabbits fed with high cholesterol diet for 8 weeks were randomly divided into two groups: (1) high cholesterol group (n = 8): maintained high cholesterol diet for 6 weeks; (2) probucol group (n = 8): the same cholesterol diet plus 1% probucol for 6 weeks. Control group (n = 8) was fed with normal diet for 14 weeks. The classical in situ two steps perfusion of the liver with collagenase IV was used to isolate the parenchymal hepatocytes. The selective uptake of HDL by hepatocytes was performed using the double radiolabelled HDL. Immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) were used to evaluate SR-BI expression in the liver.Compared with control group, rabbits fed with high cholesterol diet showed higher levels of serum total cholesterol (TC), low-density lipoprotein (LDL) cholesterol and HDL-C, all of which were significantly reduced by probucol treatment. The selective uptake of HDL CEs in probucol group (249.68 +/- 60.13 ng/mg cell protein) was about two folds higher as compared with the control group (122.47 +/- 54.06 ng/mg cell protein, P < 0.01) and high cholesterol group (104.92 +/- 47.91 ng/mg cell protein, P < 0.01), but it could not be reproduced in vitro. The expression of SR-BI were significantly decreased in the high cholesterol group (0.48 +/- 0.06) as compared with control group (0.65 +/- 0.06, P < 0.01). Probucol increased SR-BI expression (0.68 +/- 0.06, P < 0.01) as compared with high cholesterol group. The expression of SR-BI was positively associated with the selective CEs uptake (r = 0.47, P = 0.032).Probucol up-regulates SR-BI expression and enhance the uptake of HDL CEs by hepatocytes, which may help us to understand the anti-atherogenic properties and the HDL-C-lowering effect of probucol.

Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.

Effect of Probucol on Enzyme and Receptors of High Density Lipoprotein During Reverse Cholesterol Transportation in Experimental Rabbits With Atherosclerosis

Probucol alleviates atherosclerosis and improves high density lipoprotein function

The effect and mechanism of probucol on HDL function in atherosclerotic rabbits

Probucol Inhibits Atherosclerosis by Regulating ABCA1, SR-B I, ABCG5 and ABCG8 Expression and Anti-inflammatory Effects in Hypercholesterolemic Rabbits

Effect of the Anti-Oxidant Probucol on Soluble Thrombomodulin (stm) in Hypercholesterolemic Rabbits

Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits

Effects of Probucol on Metabolism of High-Density Lipoprotein in Primary Culture Hepatocytes of Hypercholesterolemic Rabbits

Combined Effects of Pravastatin and Probucol on High-Density Lipoprotein Apolipoprotein A-I Kinetics in Cholesterol-fed Rabbits.

Effect of Probucol on Macrophage Reverse Cholesterol Transport in Vivo

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.

Probucol Protects Against Atherosclerosis Through Induction of Heme Oxygenase-1

Probucol and Cilostazol Exert a Combinatorial Anti-Atherogenic Effect in Cholesterol-Fed Rabbits

Effect of Serum From Probucol-Pretreated Mice on Macrophage Cholesterol Efflux in Vitro

Effect of Atorvastatin on SR-BI Expression and HDL-induced Cholesterol Efflux in Adipocytes of Hypercholesterolemic Rabbits

Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation

Abstract 288: Atheroprotective Effect of Probucol is Related to Its Heme Oxygenase 1 Activation and Subsequent Suppression of Oxidized Low-Density Lipoprotein--Induced Dendritic Cell Maturation

Effects of Probucol on the Metabolism of High Density Lipoprotein Cholesterol and Their Mechanism

Effect and Possible Mechanism of Elsibucol Inhibiting Atherosclerosis in Experimental Rabbits

Probucol Protects Endothelial Progenitor Cells Against Oxidized Low-Density Lipoprotein via Suppression of Reactive Oxygen Species Formation In Vivo.

Effects of probucol on hepatic tumor necrosis factor-α, interleukin-6 and adiponectin receptor-2 expression in diabetic rats